10-K: DNA X Shifts Focus to Crypto Trading After Divesting Phone Business

DNA X, Inc. has completed the sale of its legacy phone and hotspot business and is now fully focused on its cryptocurrency trading platform, DNA X, while addressing going concern uncertainties.

Summary

• DNA X, Inc. has divested its legacy phone and hotspot business, completing the sale of substantially all related assets in January 2026 for $15 million.
• The company is now exclusively focused on its cryptocurrency trading platform, DNA X, which became operational in November 2025.
• The company reported a net loss of $20.66 million for the year ended December 31, 2025, compared to a net loss of $33.65 million in 2024.
• The independent auditor's report includes a statement of substantial doubt about the company's ability to continue as a going concern due to its reliance on future funding.
• The company has identified a material weakness in internal controls over financial reporting due to a lack of personnel with sufficient technical accounting expertise.
• DNA X is actively seeking additional capital to fund operations through the second quarter of 2026 and beyond.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as negative due to the substantial going concern doubt, material weakness in internal controls, and ongoing net losses, despite the strategic pivot to cryptocurrency trading.

Positives

• Successful divestiture of the legacy phone and hotspot business, generating $15 million in cash.
• Full strategic focus now on the cryptocurrency trading platform, DNA X.
• The DNA X platform has seen steady growth in trading volume since becoming operational in November 2025.
• Regained compliance with Nasdaq's stockholders equity requirement following the asset sale.

Negatives

• Reported a net loss of $20.66 million for the year ended December 31, 2025.
• The company's independent auditor has raised substantial doubt about its ability to continue as a going concern.
• Identified a material weakness in internal controls over financial reporting related to accounting for complex transactions.
• The company expects to need additional capital to fund operations through the second quarter of 2026 and beyond.
• The company's ability to continue as a going concern is dependent on its ability to raise additional funding.
• The company's cryptocurrency trading platform is not yet profitable and may not achieve profitability in the future.

Risks

• The extreme volatility of cryptocurrency prices could negatively impact trading volumes and operating results.
• The future development and growth of crypto assets are subject to unpredictable factors.
• The company's ability to compete effectively depends on developing solutions that address user needs.
• The company is dependent on the continued services and performance of a concentrated group of senior management.
• If the company's products contain defects or errors, it could incur significant unexpected expenses and be subject to liability.
• The company is required to meet Nasdaq continued listing requirements, or it may risk delisting.
• The company's membership interests in its operating subsidiary are subject to a put option that could result in the loss of its cryptocurrency trading platform if certain milestones are not met.
• Changes in laws and regulations concerning cryptocurrency trading could increase costs and adversely impact the business.
• The company may not generate sufficient revenue to operate its business and maintain its growth.

Future Outlook

The company plans to add additional features and products to the DNA X platform throughout 2026 to execute its growth strategy and will continue to monitor the platform's capacity for anticipated increases in trading volume. Marketing efforts are expected to increase as new products become available. The company anticipates needing additional capital to fund operations until it becomes cash flow positive.

Management Comments

• We are pursuing an equity transaction to ensure that we can continue to operate the DNA X trading platform until we become cash flow positive.
• Due to the uncertainty of obtaining financing, there is substantial doubt regarding the Company's ability to continue as a going concern as of the date of the filing of this Form 10-K.

Industry Context

StockSavvy.ai notes that DNA X's strategic shift from hardware manufacturing to cryptocurrency trading aligns with a broader trend of companies seeking to capitalize on the growth and potential of the digital asset market. However, the company faces significant risks inherent in the volatile cryptocurrency industry, including regulatory uncertainty and intense competition.

Legal Proceedings

• The company is subject to various laws and regulations concerning cryptocurrency trading, which are evolving.
• The company is subject to anti-corruption, economic and trade sanctions, and export control laws.
• The company is subject to privacy and data protection laws.
• The company is subject to consumer protection laws.
• The company is subject to potential litigation related to intellectual property infringement claims.

Related Party Transactions

• In 2024, the Company entered into an agreement with a related party (family member of a director) for non-recurring engineering services, which were capitalized.
• Jeffrey Wang, a former director, had family members with indirect interests in related party transactions.

Stakeholder Impact

• Shareholders may experience a decline in stock price due to going concern uncertainties and potential dilution from future capital raises.
• Creditors may be concerned about the company's ability to meet its financial obligations given the going concern warning.
• Employees may face uncertainty regarding job security due to the company's financial situation and need for restructuring.

Next Steps

• Continue to monitor the DNA X platform to ensure it can handle anticipated increases in trading volume.
• Implement marketing activities to grow trading volume.
• Seek additional capital to fund operations.
• Develop enhanced features for traders on the DNA X platform.
• Expand the number of cryptocurrencies available for trading on the platform.

Key Dates

Recommendation

The company's significant net losses, substantial going concern doubt expressed by auditors, and identified material weakness in internal controls present considerable risk. While the pivot to crypto trading offers potential, the immediate financial instability and operational control issues suggest a high-risk investment profile, warranting a sell recommendation.

Keywords

DNA X, cryptocurrency trading, Form 10-K, SEC filing, digital assets, crypto platform, going concern, financial reporting, asset sale, Sonim Technologies